Drug firm Cadila Healthcare today reported two fold increase in its net profit at

RELATED ARTICLES Ranbaxy fails to get FDA's nod, misses rights Pfizer Nov qtr net profit at Rs 137 cr Aurobindo Pharma gets tentative nod from US FDA for HIV drug Cadila Healthcare to issue bonus shares in 1:2 ratio

Rs 130 crore for the third quarter ended December 31, 2009.

The company's net profit stood at Rs 61 crore for the same quarter last fiscal, it said in a filing to the Bombay Stock Exchange.

During the quarter under consideration, the total income of the company rose to Rs 993 crore, registering growth of 31 per cent compared to Rs 761 crore for the comparable quarter last fiscal.